Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,190 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by Naima96, 12-21-2023, 07:13 AM
|
0 responses
217 views
0 reactions
|
Last Post
by Naima96
12-21-2023, 07:13 AM
|
||
|
Started by Blanch, 12-14-2023, 10:13 AM
|
0 responses
153 views
0 reactions
|
Last Post
by Blanch
12-14-2023, 10:13 AM
|
||
|
Started by Blanch, 12-14-2023, 09:58 AM
|
0 responses
200 views
0 reactions
|
Last Post
by Blanch
12-14-2023, 09:58 AM
|
||
|
Started by Dlshad, 10-20-2023, 05:26 AM
|
2 responses
218 views
0 reactions
|
Last Post
|
||
|
Started by dandreak, 10-18-2023, 09:12 AM
|
1 response
124 views
0 reactions
|
Last Post
by seqadmin
10-18-2023, 11:47 AM
|
||
|
Started by 1Rashiid, 09-23-2023, 10:04 AM
|
1 response
74 views
1 reaction
|
Last Post
by seqadmin
09-25-2023, 07:09 AM
|
||
|
Started by AnnaKo, 09-05-2023, 12:23 AM
|
1 response
58 views
0 reactions
|
Last Post
by seqadmin
09-05-2023, 10:27 AM
|
||
|
Started by hmoranmac, 08-30-2023, 09:23 AM
|
0 responses
94 views
0 reactions
|
Last Post
by hmoranmac
08-30-2023, 09:23 AM
|
||
|
Started by InGenius, 08-17-2023, 01:09 AM
|
0 responses
275 views
0 reactions
|
Last Post
by InGenius
08-17-2023, 01:09 AM
|
||
|
Started by 100%Wool, 02-14-2020, 01:45 AM
|
5 responses
3,970 views
0 reactions
|
Last Post
by Ben3
08-11-2023, 09:12 AM
|
No topics found.
-
Page of 0
-
Filter
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|